Table 2 Association between RBM3 expression and clinicopathological parameters
RBM3 staining intensity | |||
|---|---|---|---|
0-2 | 3 | ||
n(%) | 95 (44.2) | 120 (55.8) | p-value |
Age | |||
Mean | 68.00 | 67.15 | 0.673 |
(range) | (47-83) | (46-81) | |
Gender | |||
Female | 45(47.4) | 63(52.5) | 0.457 |
Male | 50(52.6) | 57(47.5) | |
Clark level | |||
II | 21(22.3) | 50(42.4) | 0.005** |
IIII | 48(51.1) | 46(39.0) | |
IV-V | 25(26.6) | 22(18.6) | |
missing | 1 | 2 | |
Breslow(mm) | |||
Mean | 2.47 | 1.12 | 0.001** |
(range) | (0.08-40.00) | (0.11-7.00) | |
Ulceration | |||
No | 71(74.7) | 109(91.6) | 0.001** |
Yes | 24(25.3) | 10(8.4) | |
missing | 0 | 1 | |
Lymphocytic | |||
infiltrate | |||
0-1 | 26(27.4) | 34(28.6) | 0.846 |
2-3 | 69(72.6) | 85(71.4) | |
missing | 0 | 1 | |
Clinical stage | |||
I | 54(76.1) | 95(91.3) | 0.005* |
II-IV | 17(23.9) | 9(8.7) | |
missing | 24 | 16 | |
Vascular invasion | |||
No | 87(91.6) | 114(95.0) | 0.314 |
Yes | 8(8.4) | 6(5.0) | |
Localization | |||
Head and neck | 15(16.0) | 16(14.0) | 0.352 |
Extremities | 40(42.6) | 59(51.8) | |
Frontal thorax | 10(10.6) | 15(13.2) | |
Dorsal thorax | 29(30.9) | 24(21.1) | |
missing | 1 | 6 | |
Type | |||
SSM, LMM, Other | 65(58.9) | 97(68.9) | 0.027* |
NMM | 30(31.6) | 22(18.5) | |
missing | 0 | 1 | |
Mitotic count | |||
< 1/mm2 | 34(35.8) | 71(59.2) | 0.001** |
> = 1/mm2 | 61(64.2) | 49(40.8) | |